|
|
|
|
|
by caf
3907 days ago
|
|
Here we're not talking about medicines with ruinously expensive approval processes, though; we're talking about gene-based diagnostic tests. Non-invasive diagnostic tests don't have anything like the same kinds of regulatory hassles, because there isn't a question of side-effects - it's purely a question of how accurate they are. |
|